Reid M. Huber's most recent trade in Rapport Therapeutics Inc. was a trade of 20,400 Common Stock done at an average price of $24.5 . Disclosure was reported to the exchange on Sept. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rapport Therapeutics Inc | Reid M. Huber | Director | Purchase of securities on an exchange or from another person at price $ 24.48 per share. | 12 Sep 2025 | 20,400 | 20,400 | - | 24.5 | 499,374 | Common Stock |
| CARGO Therapeutics Inc | Reid M. Huber | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2025 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| CARGO Therapeutics Inc | Reid M. Huber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Rapport Therapeutics Inc | Reid M. Huber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 21,850 | 21,850 | - | - | Stock Option (Right to Buy) | |
| CARGO Therapeutics Inc | Reid M. Huber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 23,742 | 23,742 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Reid M. Huber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Reid M. Huber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 5,000 | 5,000 | - | 0 | Common Stock | |
| Tango Therapeutics Inc | Reid M. Huber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) |